Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases - PubMed (original) (raw)
. 2012 Nov;56(5):1946-57.
doi: 10.1002/hep.25873. Epub 2012 Jul 26.
Affiliations
- PMID: 22684891
- PMCID: PMC3486954
- DOI: 10.1002/hep.25873
Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases
Shashi Bala et al. Hepatology. 2012 Nov.
Abstract
MicroRNAs are fine tuners of diverse biological responses and are expressed in various cell types of the liver. Here we hypothesized that circulating microRNAs (miRNAs) may serve as biomarkers of liver damage and inflammation. We studied miRNA-122, which is abundant in hepatocytes, and miR-155, -146a, and -125b, which regulate inflammation in immune cells in mouse models of alcoholic liver disease (ALD), drug (acetaminophen, APAP)-induced liver injury (DILI), and Toll-like receptor (TLR) 9+4 ligand-induced inflammatory cell-mediated liver damage. We found that serum/plasma miR-122 correlated with alanine aminotransferase (ALT) increases in the liver damage caused by alcohol, APAP, and TLR9 (CpG)+4 (LPS) ligands. MiR-155, a regulator of inflammation, was increased in serum/plasma in alcoholic and inflammatory liver injury. Alcohol failed to increase serum miR-122 in TLR4-deficient and p47phox-deficient mice that were protected from ALD. We found the most robust increase in plasma miR-122 in DILI and it correlated with the highest ALT levels. Consistent with the massive inflammatory cell infiltration in the liver, plasma miR-155 and miR-146a were significantly elevated after CpG+LPS administration. We show for the first time that, depending on the type of liver injury, circulating miRNAs are associated either with the exosome-rich or protein-rich compartments. In ALD and in inflammatory liver injury, serum/plasma miR-122 and miR-155 were predominantly associated with the exosome-rich fraction, whereas in DILI/APAP injury these miRNAs were present in the protein-rich fraction.
Conclusion: Our results suggest that circulating miRNAs may serve as biomarkers to differentiate between hepatocyte injury and inflammation and the exosome versus protein association of miRNAs may provide further specificity to mechanisms of liver pathology.
Copyright © 2012 American Association for the Study of Liver Diseases.
Figures
Fig. 1. Increased circulating miR-122 and miR-155 in alcoholic liver disease
Eight-week old C57BL/6 female mice received Liber De-Carli diet either with 5% alcohol (alcohol-fed) or isocaloric diet (pair-fed) for 5weeks. A. Hematoxylin and eosin (H&E) staining of liver sections fixed in formalin. Solid arrow indicates immune cells infiltrate, broken arrow indicates fat accumulation in hepatocytes and double arrow indicates mild necrosis of hepatocytes. B. ALT and miR-122 levels (TaqMan qRT-real time PCR) were measured in the serum as described in methods (n=6–8). C. Correlation between serum ALT and serum miR-122 was determined by Pearson method (n=30). D. The protein level of TNFα was measured from the whole cell lysate of liver homogenates by ELISA and normalized to protein concentration (n=6–8). E. MiR-155 expression was detected in the serum by TaqMan qRT-real time PCR (n=5). Synthetic C. elegans miR-39 was used to normalize Ct values. Fold change was calculated compared to pair-fed mice. Data represent mean ± SEM. Statistical analysis was performed with Two-tailed t-test (B&D) or non-parametric Mann-Whitney test (E).
Fig. 2. TLR4 deficiency or disruption of oxidative stress prevents increased serum miR-122 in ALD
Wild type (WT) or TLR4- or p47phox - deficient mice (KO) were fed with isocaloric (pair-fed) or alcohol (ethanol-fed) containing Liber De-Carli diet for 5 weeks. A. H&E staining of formalin fixed liver sections from WT and TLR4KO mice. B. Serum ALT analysis of WT and TLR4KO mice (n=6–7). C. The expression of miR-122 in the serum isolated from WT and TLR4KO mice was quantified by TaqMan qRT-real time PCR (n=5–7). D. Histopathology (H&E) of liver sections from WT and p47phox KO mice. E. Serum ALT analysis of WT and p47phox KO mice (n=6–7). F. The expression of miR-122 in the serum was determined by TaqMan qRT-real time PCR in WT and p47phox KO mice (n=6). Spiked C. elegans miR-39 was used to normalize Ct values. Fold change was calculated compared to pair-fed mice. Data represent mean ± SEM. Two-tailed T-Test (B,C&E) or non-parametric Mann-Whitney test (F) was employed for statistical analysis.
Fig. 3. APAP administration induces a time-dependent increase of miRNA in the plasma
Wild type female mice (8 weeks old) were fasted overnight as describes in methods and next day, some mice received saline or APAP (500mg/kg, lethal dose) for 3h or 6h. A. H&E staining of formalin fixed liver sections. Broken arrows indicate centrilobular cytoplasmic vacuoles, solid arrows indicate large cytoplasmic vacuoles and double arrows indicate extensive parenchymal hemorrhages. B. Plasma ALT levels (n=8). C. The expression of miR-122 in the plasma was quantified by TaqMan qRT-real time (n=8). D. Correlation between plasma ALT and miR-122 was determined by Pearson method (n=23). E-F. The relative expression of miR-155 (E), -146a (F left) and miR-125b (F right) in plasma was determined by TaqMan qRT-real time PCR (n=8). Spiked C. elegans miR-39 was used as internal control. Fold change over saline treated mice is shown. Data represent mean ± SEM. Non-parametric Mann-Whitney test was employed for statistical analysis.
Fig. 4. Increased plasma miRNA-122, -155 and -146a in CpG+LPS-induced liver inflammation
Wild type female mice (10–12 weeks old) were injected with 2.5mg/kg CpG DNA (i.p.) once a day for three days and on day 4 some mice received 0.5mg/kg LPS or saline for 3h and sacrificed. A. H&E staining of formalin fixed liver sections. Broken arrow indicates mononuclear inflammatory cells and solid arrows indicate inflammatory foci B. Plasma ALT levels (n=4–6). C. The expression of miR-122 in the plasma was quantified by TaqMan qRT-real time (n=4–6). D. Correlation between plasma ALT and miR-122 was determined by Pearson method (n=17). E. The expression of TNFα was measured by real time PCR using TNFα gene-specific primer and normalized to 18S. F. The relative expression of miR-155 (left) and miR-146a (right) in plasma was determined by TaqMan qRT-real time PCR and spiked C. elegans miR-39 was used as internal control (n=4–6). Fold change over saline treated mice is shown. Data represent mean ± SEM. Non-parametric Mann-Whitney test was employed for statistical analysis.
Fig. 5. Circulating miRNAs localize to the exosome-rich or protein-rich compartments in a liver injury-specific manner
Exosome-rich or protein-rich fractions were isolated with ExoQuick Exosome Precipitation solution (SBI, System Biosciences) from serum or plasma as described in methods and lysed with QIAzole (Qiagen). Total RNA was isolated with miRNeasy kit (Qiagen) and used for miRNA detection. The expression of miR-122 and miR-155 was quantified in exosome-rich or protein-rich fractions isolated from serum (A left & right; ALD model) and plasma (C left & right; APAP model and E left & right; CpG model). B&D&F Expression of miR-122 and miR-155 was quantified in the liver after alcohol (B), APAP (D) and CpG+LPS (F) treatments (n=4–8). Spiked C. elegans miR-39 (serum or plasma) and SnoRNA202 (liver) was used as internal control. The fold change over pair-fed (5A,B) or saline (5C–F) treated mice is shown. Data represent mean ± SEM. * p<0.05 compared to saline treated mice. Non-parametric Mann-Whitney test was employed for statistical analysis.
Comment in
- Circulating MicroRNA-122 signature in nonalcoholic fatty liver disease and cardiovascular disease: a new endocrine system in metabolic syndrome.
Pirola CJ, Gianotti TF, Castaño GO, Sookoian S. Pirola CJ, et al. Hepatology. 2013 Jun;57(6):2545-7. doi: 10.1002/hep.26116. Epub 2013 Mar 6. Hepatology. 2013. PMID: 23111985 No abstract available. - Reply: To PMID 22684891.
Szabo G, Bala S. Szabo G, et al. Hepatology. 2013 Jun;57(6):2547. doi: 10.1002/hep.26111. Epub 2013 May 28. Hepatology. 2013. PMID: 23112144 No abstract available.
Similar articles
- Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury.
Vliegenthart AD, Shaffer JM, Clarke JI, Peeters LE, Caporali A, Bateman DN, Wood DM, Dargan PI, Craig DG, Moore JK, Thompson AI, Henderson NC, Webb DJ, Sharkey J, Antoine DJ, Park BK, Bailey MA, Lader E, Simpson KJ, Dear JW. Vliegenthart AD, et al. Sci Rep. 2015 Oct 22;5:15501. doi: 10.1038/srep15501. Sci Rep. 2015. PMID: 26489516 Free PMC article. - Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
Momen-Heravi F, Saha B, Kodys K, Catalano D, Satishchandran A, Szabo G. Momen-Heravi F, et al. J Transl Med. 2015 Aug 12;13:261. doi: 10.1186/s12967-015-0623-9. J Transl Med. 2015. PMID: 26264599 Free PMC article. - Circulating microRNAs as potential markers of human drug-induced liver injury.
Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM, Neoptolemos JP, Moggs J, Goldring CE, Park BK. Starkey Lewis PJ, et al. Hepatology. 2011 Nov;54(5):1767-76. doi: 10.1002/hep.24538. Hepatology. 2011. PMID: 22045675 Clinical Trial. - The functional role of microRNAs in alcoholic liver injury.
McDaniel K, Herrera L, Zhou T, Francis H, Han Y, Levine P, Lin E, Glaser S, Alpini G, Meng F. McDaniel K, et al. J Cell Mol Med. 2014 Feb;18(2):197-207. doi: 10.1111/jcmm.12223. Epub 2014 Jan 8. J Cell Mol Med. 2014. PMID: 24400890 Free PMC article. Review. - Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury.
Yang X, Weng Z, Mendrick DL, Shi Q. Yang X, et al. Toxicol Lett. 2014 Mar 21;225(3):401-6. doi: 10.1016/j.toxlet.2014.01.013. Epub 2014 Jan 21. Toxicol Lett. 2014. PMID: 24462978 Review.
Cited by
- microRNAs and Other Serological Markers of Liver Fibrosis in Patients with Alcohol-Related Liver Cirrhosis.
Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Szczygieł K, Tywanek E, Cichoż-Lach H. Michalak A, et al. Biomedicines. 2024 Sep 16;12(9):2108. doi: 10.3390/biomedicines12092108. Biomedicines. 2024. PMID: 39335621 Free PMC article. - Biological functions and affected signaling pathways by Long Non-Coding RNAs in the immune system.
Ghahramani Almanghadim H, Karimi B, Valizadeh S, Ghaedi K. Ghahramani Almanghadim H, et al. Noncoding RNA Res. 2024 Sep 6;10:70-90. doi: 10.1016/j.ncrna.2024.09.001. eCollection 2025 Feb. Noncoding RNA Res. 2024. PMID: 39315339 Free PMC article. Review. - Dynamic role of exosomal long non-coding RNA in liver diseases: pathogenesis and diagnostic aspects.
Ismail M, Fadul MM, Taha R, Siddig O, Elhafiz M, Yousef BA, Jiang Z, Zhang L, Sun L. Ismail M, et al. Hepatol Int. 2024 Sep 21. doi: 10.1007/s12072-024-10722-1. Online ahead of print. Hepatol Int. 2024. PMID: 39306594 Review. - Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis.
Xiao Y, Yuan Y, Hu D, Wang H. Xiao Y, et al. J Immunol Res. 2024 Jul 25;2024:4481452. doi: 10.1155/2024/4481452. eCollection 2024. J Immunol Res. 2024. PMID: 39104595 Free PMC article. Review. - Endogenous ethanol production in health and disease.
Meijnikman AS, Nieuwdorp M, Schnabl B. Meijnikman AS, et al. Nat Rev Gastroenterol Hepatol. 2024 Aug;21(8):556-571. doi: 10.1038/s41575-024-00937-w. Epub 2024 Jun 3. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38831008 Review.
References
- Ambros V. The functions of animal microRNAs. Nature. 2004;7006:350–355. - PubMed
- Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;10:997–1006. - PubMed
- Ji F, Yang B, Peng X, Ding H, You H, Tien P. Circulating microRNAs in hepatitis B virus-infected patients. J Viral Hepat. 2011;7:e242–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AA017729/AA/NIAAA NIH HHS/United States
- R01 DK075635/DK/NIDDK NIH HHS/United States
- R01 AA017729/AA/NIAAA NIH HHS/United States
- AA020744/AA/NIAAA NIH HHS/United States
- DK075635/DK/NIDDK NIH HHS/United States
- R01 AA020744/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical